These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2766251)

  • 1. Specificity of asbestos-induced chromosomal aberrations in short-term cultured human mesothelial cells.
    Olofsson K; Mark J
    Cancer Genet Cytogenet; 1989 Aug; 41(1):33-9. PubMed ID: 2766251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.
    Tiainen M; Tammilehto L; Rautonen J; Tuomi T; Mattson K; Knuutila S
    Br J Cancer; 1989 Oct; 60(4):618-26. PubMed ID: 2803935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis of malignant mesothelioma.
    Hagemeijer A; Versnel MA; Van Drunen E; Moret M; Bouts MJ; van der Kwast TH; Hoogsteden HC
    Cancer Genet Cytogenet; 1990 Jul; 47(1):1-28. PubMed ID: 2357680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenesis and related cell and tissue responses to asbestos: a review.
    Mossman BT
    Ann Occup Hyg; 1994 Aug; 38(4):617-24, 423. PubMed ID: 7978984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant mesothelioma: clinical characteristics, asbestos mineralogy and chromosomal abnormalities of 41 patients.
    Tammilehto L; Tuomi T; Tiainen M; Rautonen J; Knuutila S; Pyrhönen S; Mattson K
    Eur J Cancer; 1992; 28A(8-9):1373-9. PubMed ID: 1325175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gap junctional intercellular communication of primary and asbestos-associated malignant human mesothelial cells.
    Linnainmaa K; Pelin K; Vanhala E; Tuomi T; Piccoli C; Fitzgerald DJ; Yamasaki H
    Carcinogenesis; 1993 Aug; 14(8):1597-602. PubMed ID: 8394779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological aspects of asbestos-related diseases].
    Kanceljak-Macan B
    Arh Hig Rada Toksikol; 2009 Nov; 60 Suppl():45-50. PubMed ID: 20853778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monosomy 14, monosomy 22 and 13q--three chromosomal abnormalities observed in cells of two malignant mesotheliomas studied by banding techniques.
    Mark J
    Acta Cytol; 1978; 22(5):398-401. PubMed ID: 281850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic hybridisation in malignant deciduoid mesothelioma.
    Scattone A; Pennella A; Gentile M; Musti M; Nazzaro P; Buonadonna AL; Marzullo A; Cavone D; Pollice L; Serio G
    J Clin Pathol; 2006 Jul; 59(7):764-9. PubMed ID: 16569690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients.
    Pelin-Enlund K; Husgafvel-Pursiainen K; Tammilehto L; Klockars M; Jantunen K; Gerwin BI; Harris CC; Tuomi T; Vanhala E; Mattson K
    Carcinogenesis; 1990 Apr; 11(4):673-81. PubMed ID: 2323006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesothelioma in a factory using amosite and chrysotile asbestos.
    Acheson ED; Bennett C; Gardner MJ; Winter PD
    Lancet; 1981 Dec 19-26; 2(8260-61):1403-6. PubMed ID: 6118770
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.
    Ke Y; Reddel RR; Gerwin BI; Reddel HK; Somers AN; McMenamin MG; LaVeck MA; Stahel RA; Lechner JF; Harris CC
    Am J Pathol; 1989 May; 134(5):979-91. PubMed ID: 2541616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonrandom chromosomal abnormalities in malignant pleural mesothelioma.
    Tiainen M; Tammilehto L; Mattson K; Knuutila S
    Cancer Genet Cytogenet; 1988 Jul; 33(2):251-74. PubMed ID: 3164248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo studies of mesothelioma.
    Pass HI; Mew DJ
    J Cell Biochem Suppl; 1996; 24():142-51. PubMed ID: 8806096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Asbestos and malignant pleural mesothelioma: molecular, cellular and physiopathological aspects].
    Mohr S; Keith G; Rihn B
    Bull Cancer; 2005 Nov; 92(11):959-76. PubMed ID: 16316830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Massive exposure to asbestos and malignant mesothelioma, familial accumulation].
    Otte KE; Sigsgaard TI; Kjaerulff J
    Ugeskr Laeger; 1990 Oct; 152(41):3013-4. PubMed ID: 2173188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial pleural mesothelioma with environmental asbestos exposure: losses of DNA sequences by comparative genomic hybridization (CGH).
    Serio G; Scattone A; Gentile M; Nazzaro P; Pennella A; Buonadonna AL; Pollice L; Musti M
    Histopathology; 2004 Dec; 45(6):643-5. PubMed ID: 15569059
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation and chromosomal analysis of cell lines derived from mesotheliomas induced in rats with erionite and UICC chrysotile asbestos.
    Palekar LD; Eyre JF; Coffin DL
    IARC Sci Publ; 1989; (90):167-72. PubMed ID: 2545605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The incidence of malignant mesothelioma (1977-1996) and asbestos exposure in the population of an area neighboring Lake Iseo, northern Italy].
    Barbieri PG; Migliori M; Merler E
    Med Lav; 1999; 90(6):762-75. PubMed ID: 10703192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic response to asbestos fibers in cultured human primary mesothelial cells from 10 different donors.
    Pelin K; Hirvonen A; Taavitsainen M; Linnainmaa K
    Mutat Res; 1995 Apr; 334(2):225-33. PubMed ID: 7885376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.